Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

OLMETEC 40 MG COMPRIMIDOS RECUBIERTOS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/OLMETEC 40 MG COMPRIMIDOS RECUBIERTOS

Approved

STANDARD

OLMETEC 40 MG COMPRIMIDOS RECUBIERTOS

Daiichi Sankyo Italia S.P.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 23, 2024
Approval ID: e37120d3ba3d09bf
Company: Daiichi Sankyo Italia S.P.A.
Type: Standard

Approval Details

Approval Id: e37120d3ba3d09bf
Drug Cima Aemps Name: OLMETEC 40 MG COMPRIMIDOS RECUBIERTOS
Register Number: 036027112IP2
Holder Company Name: Daiichi Sankyo Italia S.P.A.
Marketing Company Name: Elam Pharma Labs S.L.
Authorization Date: 2024-05-23
Dosage Form: COMPRIMIDO RECUBIERTO
Dose: 40 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Daiichi Sankyo Italia S.P.A.

Active Ingredients

OLMESARTAN MEDOXOMILO

40 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 23, 2024

Approval ID

e37120d3ba3d09bf

Type

Standard

Back to CIMA-AEMPS Approvals